Porphyria Cutanea Tarda in a Patient with End-Stage Renal Disease: A Case of Successful Treatment with Deferoxamine and Ferric Carboxymaltose

Table 1

Laboratory results.

	Result	Reference
Haemoglobin	104 g/L	100–120 g/L
WBC count	6.06 × 10^9/L	3.8–10.8 × 10^9/L
Platelet count	138 × 10^9/L	150–450 × 10^9/L
C-reactive protein	0.04 mg/L	<0.8 mg/L
Transferrin saturation	43%	>30%
Ferritin	267 µg/L	200–500 µg/L
ALT	53 U/L	<20 U/L
AST	34 U/L	<42 U/L
G-GT	133 U/L	8–65 U/L
Total plasma porphyrin	1052.3 ug/L	<32.5 ug/L
Plasma uroporphyrin	983.3 ug/L	< 11.8 ug/L
Plasma heptacarboxylporphyrin	24.3 ug/L	<3.8 ug/L
Plasma hexacarboxylporphyrin	13.4 ug/L	<1.3 ug/L
Plasma pentacarboxylporphyrin	27.3 ug/L	<27.3 ug/L
Plasma coproporphyrin I	2.5 ug/L	<6.4 ug/L
Plasma coproporphyrin II	1.5 ug/L	<8 ug/L
Faecal porphyrins	All normal
Urinary porphyrins	Anuric

ALT, alanine aminotransferase; AST, aspartate aminotransferase; G-GT, gamma-glutamate transpeptidase. The reference values for haemoglobin, ferritin, and transferrin saturation are in concordance with KDIGO considering ESRD patients.